-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Edmund J. Pezalla, MD, MPH

Articles by Edmund J. Pezalla, MD, MPH

Genomic Testing in Oncology to Improve Clinical Outcomes While Optimizing Utilization: the Evolution of Diagnostic Testing

ByDavid C. Collymore, MD, MBA,Shaunna L. Kobilis, RN, BSN, OCN,Thomas G. Lundquist, MD, MMM, FAAP, FACPE,William T. McGivney, PhD,Edmund J. Pezalla, MD, MPH,Wendy Poage, MHA

February 19th 2016

Practical Perspectives on the Management of Overweight and Obesity

ByRobert S. Gregory, RPh, MS, MBA,Yehuda Handelsman, MD, FACP, FACE, FNLA,Edmund J. Pezalla, MD, MPH,Dan Pikelny, MA, MBA

March 20th 2014

Participating Faculty: Practical Perspectives on the Management of Overweight and Obesity

ByRobert S. Gregory, RPh, MS, MBA,Yehuda Handelsman, MD, FACP, FACE, FNLA,Edmund J. Pezalla, MD, MPH,Dan Pikelny, MA, MBA

March 18th 2014

Considerations for the Optimal Use of Immunoglobulin

ByRobert P. Navarro, PharmD,Mark Ballow, MD,Beckie Fenrick, PharmD, MBA,Edmund J. Pezalla, MD, MPH

June 18th 2012

Latest Updated Articles

Genomic Testing in Oncology to Improve Clinical Outcomes While Optimizing Utilization: the Evolution of Diagnostic Testing
February 19th 2016
Considerations for the Optimal Use of Immunoglobulin
June 18th 2012
Participating Faculty: Practical Perspectives on the Management of Overweight and Obesity
March 18th 2014
Practical Perspectives on the Management of Overweight and Obesity
March 20th 2014

Trending on AJMC

ATTR-CM Incidence, Prevalence Rose Sharply in the US

Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes

Natera's Moshkevich Discusses TOMR Approach and the Future of MRD-Guided Care